drugset / Trial / NCT06225076

Efficacy of Stellate Ganglion Block in Dysphagic Patients With Bulbar Palsy After Ischemic Stroke

NCT06225076 ↗

Withdrawn Zeng Changhao
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a randomized controlled study, including dysphagic patients with bulbar palsy after ischemic stroke who were received in the department of rehabilitation medicine in 3 hospitals in China. All patients are randomly allocated to the observation group or the control group. Both groups are provided with comprehensive rehabilitation. Besides, the observation group additionally undergoes the stellate ganglion block. At admission and after 20-day treatment, video fluoroscopic swallowing study, and penetration-aspiration scale, Functional Oral Intake Scale, Flexible laryngoscope are used to assess swallowing function.

Timeline

Start
2024-01-30
Primary completion
2024-04-15
Completion
2024-05-30

Outcome

Outcome not reported

Stopped: “ethical issues”

Drugs

EvaluationDrugModalityDoseRoute
Background Lidocaine Other / unclassified 1.5 ml Other

Indications